Rapid and indirect inhibition of organic anion transporting polypeptide (OATP) 1B1 transport activity by lysosomotropic drug chloroquine: implications in OATP-mediated drug-drug interactions

被引：0
|
作者：
Alam, Khondoker [1 ]
Abuznait, Alaa [1 ]
Pahwa, Sonia [1 ]
Wang, Xueying [2 ]
Zhang, Pengyue [2 ]
Ding, Kai [3 ]
Li, Lang [2 ]
Yue, Wei [1 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Pharmaceut Sci, Oklahoma City, OK 73190 USA
[2] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA
[3] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK USA
来源：
DRUG METABOLISM REVIEWS | 2016年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P268
引用
收藏
页码：152 / 152
页数：1
相关论文
共 50 条
  • [41] Scutellarin is Highly Likely to be Responsible for Drug-Drug Interactions Mediated by Hepatic Organic Anion-Transporting Polypeptide1B3
    Jianming Liu
    Yongmei Guo
    Yanqi Xu
    Li Yuan
    Huiting Zhu
    Pharmaceutical Research, 2020, 37
  • [42] Organic Anion Transporting Polypeptide 1B1 (OATP1B1) and OATP1B3: Genetic Variability and Haplotype Analysis in White Canadians
    Boivin, Andree-Anne
    Cardinal, Heloise
    Barama, Azemi
    Pichette, Vincent
    Hebert, Marie-Josee
    Roger, Michel
    DRUG METABOLISM AND PHARMACOKINETICS, 2010, 25 (05) : 508 - 515
  • [43] Role of the murine organic anion-transporting polypeptide 1b2 (Oatp1b2) in drug disposition and hepatotoxicity
    Evers, Raymond
    Chu, Xiao-Yan
    MOLECULAR PHARMACOLOGY, 2008, 74 (02) : 309 - 311
  • [44] Molecular localization and characterization of multiple binding sites of organic anion transporting polypeptide 2B1 (OATP2B1) as the mechanism for substrate and modulator dependent drug-drug interaction
    Hoshino, Yusuke
    Fujita, Daichi
    Nakanishi, Takeo
    Tamai, Ikumi
    MEDCHEMCOMM, 2016, 7 (09) : 1775 - 1782
  • [45] ORGANIC ANION TRANSPORTER POLYPEPTIDE (OATP) MEDIATED DRUG INTERACTIONS BETWEEN RIFAMPIN AND LINEZOLID, IN VITRO.
    Kaisar, N.
    Parvez, M.
    Lee, Y.
    Shin, H.
    Lee, D.
    Jung, J.
    Shin, J-G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S32 - S32
  • [46] In Vitro-ln Vivo Extrapolation of OATP1B-Mediated Drug-Drug Interactions in Cynomolgus Monkey
    Ufuk, Ayse
    Kosa, Rachel E.
    Gao, Hongying
    Bi, Yi-An
    Modi, Sweta
    Gates, Dana
    Rodrigues, A. David
    Tremaine, Larry M.
    Varma, Manthena V. S.
    Houston, J. Brian
    Galetin, Aleksandra
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 365 (03): : 688 - 699
  • [47] Quantitative prediction of OATP1B-mediated drug-drug interactions using endogenous biomarker coproporphyrin I
    Takubo, Hiroaki
    Bessho, Koji
    Watari, Ryosuke
    Shigemi, Ryota
    XENOBIOTICA, 2022, 52 (04) : 397 - 404
  • [48] Interactions of crizotinib and gefitinib with organic anion-transporting polypeptides (OATP)1B1, OATP1B3 and OATP2B1: gefitinib shows contradictory interaction with OATP1B3
    Sato, Toshihiro
    Ito, Hajime
    Hirata, Ayaka
    Abe, Takaaki
    Mano, Nariyasu
    Yamaguchi, Hiroaki
    XENOBIOTICA, 2018, 48 (01) : 73 - 78
  • [49] CLINICAL VALIDATION AND UTILITY OF COPROPORPHYRINS AS ENDOGENOUS PROBES TO PREDICT OATP1B-MEDIATED DRUG-DRUG INTERACTIONS
    Shen, Hong
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : S12 - S12
  • [50] Biomarker-Informed Model-Based Risk Assessment of Organic Anion Transporting Polypeptide 1B Mediated Drug-Drug Interactions
    Kimoto, Emi
    Costales, Chester
    West, Mark A.
    Bi, Yi-an
    Vourvahis, Manoli
    Rodrigues, A. David
    Varma, Manthena V. S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (02) : 404 - 415
12345